A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants.
Phase of Trial: Phase I/II
Latest Information Update: 21 Jan 2018
At a glance
- Drugs TDENV LAV (Primary)
- Indications Dengue
- Focus Adverse reactions; Pharmacodynamics
- Acronyms Infant study
- 15 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Sep 2010 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.
- 11 Oct 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History